| Budget Amount *help |
¥17,030,000 (Direct Cost: ¥13,100,000、Indirect Cost: ¥3,930,000)
Fiscal Year 2012: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2011: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2010: ¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2009: ¥7,930,000 (Direct Cost: ¥6,100,000、Indirect Cost: ¥1,830,000)
|
|---|
| Research Abstract |
We demonstrated the activation of Akt-mTOR pathway in leiomyosarcoma, synovial sarcoma, malignant peripheral nerve sheath tumor, myxofibrosarcoma, solitary fibrous tumor and dermatofibrosarcoma protuberans. Activation of this pathway was correlated with histopathological malignancy and poor prognosis in these tumors. Therefore, Akt-mTOR pathway may be the candidate of molecular target in these non-small round cell sarcomas
|
